Xylem (XYL) Financials

$125.58 -0.07 (-0.06%)

Closing price 03:59 PM Eastern

Extended Trading

$125.31 -0.27 (-0.22%)

As of 07:49 PM Eastern

Annual Income Statements for Xylem

This table shows Xylem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	890	609	355	427	254	401	549	331	260	340
Consolidated Net Income / (Loss)	890	609	355	427	254	401	549	330	260	340
Net Income / (Loss) Continuing Operations	890	609	355	427	254	401	549	330	260	340
Total Pre-Tax Income	1,087	635	440	511	285	416	585	466	340	403
Total Operating Income	1,009	652	622	585	367	486	654	552	408	449
Total Gross Profit	3,212	2,717	2,084	1,975	1,830	2,046	2,026	1,847	1,462	1,404
Total Revenue	8,562	7,364	5,522	5,195	4,876	5,249	5,207	4,707	3,771	3,653
Operating Revenue	8,562	7,364	5,522	5,195	4,876	5,249	5,207	4,707	3,771	3,653
Total Cost of Revenue	5,350	4,647	3,438	3,220	3,046	3,203	3,181	2,860	2,309	2,249
Operating Cost of Revenue	5,350	4,647	3,438	3,220	3,046	3,203	3,181	2,860	2,309	2,249
Total Operating Expenses	2,203	2,065	1,462	1,390	1,463	1,560	1,372	1,295	1,054	955
Selling, General & Admin Expense	1,911	1,757	1,227	1,179	1,143	1,158	1,161	1,089	914	854
Research & Development Expense	230	232	206	204	187	191	189	181	110	95
Impairment Charge	62	76	29	7.00	133	211	22	0.00	-	-
Other Special Charges / (Income)	0.00	0.00	-	0.00	0.00	-	-	-	-	-
Total Other Income / (Expense), net	78	-17	-182	-74	-82	-70	-69	-86	-68	-46
Interest Expense	44	49	50	76	77	67	82	82	70	55
Interest & Investment Income	152	0.00	0.00	-	-	-	-	-	-	-
Other Income / (Expense), net	-30	32	-132	2.00	-5.00	-3.00	13	-4.00	2.00	9.00
Income Tax Expense	197	26	85	84	31	15	36	136	80	63
Basic Earnings per Share	$3.67	$2.81	$1.97	$2.37	$1.41	$2.23	$3.05	$1.84	$1.45	$1.88
Weighted Average Basic Shares Outstanding	242.58M	217.01M	180.22M	180.25M	180.12M	179.99M	179.78M	179.60M	179.11M	180.89M
Diluted Earnings per Share	$3.65	$2.79	$1.96	$2.35	$1.40	$2.21	$3.03	$1.83	$1.45	$1.87
Weighted Average Diluted Shares Outstanding	243.52M	218.18M	180.98M	181.53M	181.10M	181.20M	181.13M	180.90M	180.04M	181.74M
Weighted Average Basic & Diluted Shares Outstanding	243.05M	241.77M	180.28M	179.90M	180.36M	180.22M	180M	179.90M	179.30M	180.90M
Cash Dividends to Common per Share	$1.44	$1.32	$1.20	$1.12	$1.04	$0.96	$0.84	$0.72	$0.62	$0.56

This table shows Xylem's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	169	326	217	194	153	266	152	92	99	149	12
Consolidated Net Income / (Loss)	167	326	217	194	153	266	152	92	99	149	12
Net Income / (Loss) Continuing Operations	167	326	217	194	153	266	152	92	99	149	12
Total Pre-Tax Income	217	375	269	247	196	210	185	114	126	189	17
Total Operating Income	231	267	280	253	209	211	191	119	131	197	168
Total Gross Profit	768	857	784	819	752	756	764	651	546	573	524
Total Revenue	2,069	2,256	2,104	2,169	2,033	2,118	2,076	1,722	1,448	1,506	1,380
Operating Revenue	2,069	2,256	2,104	2,169	2,033	2,118	2,076	1,722	1,448	1,506	1,380
Total Cost of Revenue	1,301	1,399	1,320	1,350	1,281	1,362	1,312	1,071	902	933	856
Operating Cost of Revenue	1,301	1,399	1,320	1,350	1,281	1,362	1,312	1,071	902	933	856
Total Operating Expenses	537	590	504	566	543	545	573	532	415	376	356
Selling, General & Admin Expense	460	507	445	485	474	466	491	446	354	315	294
Research & Development Expense	56	58	55	58	59	60	61	58	53	54	47
Impairment Charge	21	25	4.00	23	10	19	21	28	8.00	7.00	15
Total Other Income / (Expense), net	-14	108	-11	-6.00	-13	-1.00	-6.00	-5.00	-5.00	-8.00	-151
Interest Expense	8.00	9.00	10	11	14	14	14	12	9.00	13	12
Other Income / (Expense), net	-6.00	-35	-1.00	5.00	1.00	13	8.00	7.00	4.00	5.00	-139
Income Tax Expense	50	49	52	53	43	-56	33	22	27	40	5.00
Net Income / (Loss) Attributable to Noncontrolling Interest	-2.00	-	-	-	-	-	-	-	-	-	-
Basic Earnings per Share	$0.69	$1.35	$0.89	$0.80	$0.63	$1.18	$0.63	$0.45	$0.55	$0.83	$0.07
Weighted Average Basic Shares Outstanding	243.11M	242.58M	242.93M	242.57M	241.85M	217.01M	240.87M	205.54M	180.40M	180.22M	180.22M
Diluted Earnings per Share	$0.69	$1.33	$0.89	$0.80	$0.63	$1.17	$0.63	$0.45	$0.54	$0.82	$0.07
Weighted Average Diluted Shares Outstanding	243.78M	243.52M	243.75M	243.54M	243.02M	218.18M	242.19M	206.74M	181.32M	180.98M	180.94M
Weighted Average Basic & Diluted Shares Outstanding	243.35M	243.05M	242.94M	242.89M	242.45M	241.77M	241.08M	240.83M	180.62M	180.28M	180.22M
Cash Dividends to Common per Share	$0.40	-	$0.36	-	-	-	$0.33	-	-	-	$0.30

This table details how cash moves in and out of Xylem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	102	75	-405	-526	1,151	428	-118	106	-372	17
Net Cash From Operating Activities	1,263	837	596	538	824	839	586	686	497	464
Net Cash From Continuing Operating Activities	1,263	837	596	538	824	839	586	686	497	464
Net Income / (Loss) Continuing Operations	890	609	355	427	254	401	549	330	260	340
Consolidated Net Income / (Loss)	890	609	355	427	254	401	549	330	260	340
Depreciation Expense	258	193	111	118	117	117	117	109	87	88
Amortization Expense	304	243	125	127	134	140	144	125	64	45
Non-Cash Adjustments To Reconcile Net Income	-9.00	112	182	17	178	229	20	42	27	-1.00
Changes in Operating Assets and Liabilities, net	-180	-320	-177	-151	141	-48	-244	80	59	-8.00
Net Cash From Investing Activities	-482	-628	-191	-183	-169	-231	-643	-181	-1,886	-132
Net Cash From Continuing Investing Activities	-482	-628	-191	-183	-169	-231	-643	-181	-1,886	-132
Purchase of Property, Plant & Equipment	-321	-271	-208	-208	-183	-226	-237	-170	-124	-117
Acquisitions	-199	-533	-3.00	-5.00	-	-18	-433	-33	-1,782	-18
Purchase of Investments	-11	-1.00	-21	0.00	-200	-7.00	-11	-11	0.00	0.00
Sale of Property, Plant & Equipment	4.00	1.00	4.00	3.00	-	-	-	1.00	1.00	0.00
Divestitures	11	105	1.00	10	0.00	0.00	22	16	0.00	1.00
Sale and/or Maturity of Investments	35	29	33	14	212	20	11	10	0.00	0.00
Other Investing Activities, net	-1.00	42	3.00	3.00	2.00	0.00	5.00	6.00	19	2.00
Net Cash From Financing Activities	-615	-157	-790	-855	473	-177	-40	-421	1,034	-262
Net Cash From Continuing Financing Activities	-615	-157	-790	-855	473	-177	-40	-421	1,034	-262
Repayment of Debt	-313	-173	-529	-603	-642	-257	-172	-282	-688	-4.00
Repurchase of Common Equity	-20	-25	-52	-68	-61	-40	-59	-25	-4.00	-179
Payment of Dividends	-350	-299	-217	-203	-188	-174	-152	-130	-112	-102
Issuance of Debt	1.00	278	0.00	0.00	1,344	281	336	0.00	1,814	0.00
Other Financing Activities, net	67	62	8.00	19	20	13	7.00	16	24	23
Effect of Exchange Rate Changes	-53	23	-20	-26	23	-3.00	-21	22	-17	-53
Cash Interest Paid	67	69	76	99	77	77	78	78	49	52
Cash Income Taxes Paid	219	211	91	83	41	107	75	57	78	75

This table details how cash moves in and out of Xylem's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-62	132	174	-132	-72	314	-3.00	-129	-107	-242	73
Net Cash From Operating Activities	33	575	311	288	89	455	373	28	-19	362	202
Net Cash From Continuing Operating Activities	33	575	311	288	89	455	373	28	-19	362	202
Net Income / (Loss) Continuing Operations	169	326	217	194	153	266	152	92	99	149	12
Consolidated Net Income / (Loss)	169	326	217	194	153	266	152	92	99	149	12
Depreciation Expense	68	67	68	62	61	61	63	41	28	28	27
Amortization Expense	77	75	73	83	73	76	84	51	32	32	31
Non-Cash Adjustments To Reconcile Net Income	54	-91	18	33	31	30	24	35	23	2.00	150
Changes in Operating Assets and Liabilities, net	-335	198	-65	-84	-229	22	50	-191	-201	151	-18
Net Cash From Investing Activities	-15	-289	-65	-77	-51	-89	-50	-452	-37	-68	-39
Net Cash From Continuing Investing Activities	-15	-289	-65	-77	-51	-89	-50	-452	-37	-68	-39
Purchase of Property, Plant & Equipment	-71	-100	-74	-73	-74	-94	-74	-54	-49	-60	-53
Acquisitions	-8.00	-190	-2.00	-	-	1.00	-2.00	-	-	-1.00	-1.00
Purchase of Investments	0.00	-3.00	-1.00	-5.00	-2.00	-	-1.00	-	0.00	-12	-2.00
Sale of Property, Plant & Equipment	5.00	1.00	-	2.00	1.00	-1.00	2.00	-	0.00	1.00	-
Divestitures	48	-	-	-	11	2.00	12	91	0.00	-	-
Sale and/or Maturity of Investments	12	5.00	12	5.00	13	3.00	12	1.00	13	4.00	14
Other Investing Activities, net	-1.00	-2.00	-	1.00	0.00	-	1.00	42	-1.00	-	3.00
Net Cash From Financing Activities	-116	-95	-101	-337	-82	-86	-306	298	-63	-580	-52
Net Cash From Continuing Financing Activities	-116	-95	-101	-337	-82	-86	-306	298	-63	-580	-52
Repayment of Debt	-12	-9.00	-15	-277	-12	-10	-157	-4.00	-2.00	-528	-2.00
Repurchase of Common Equity	-13	-1.00	-1.00	-3.00	-15	-15	-1.00	-1.00	-8.00	-	-
Payment of Dividends	-98	-87	-88	-87	-88	-80	-80	-79	-60	-54	-53
Issuance of Debt	1.00	1.00	-	-	-	2.00	-73	-	-	-	-
Other Financing Activities, net	6.00	1.00	3.00	30	33	17	5.00	33	7.00	2.00	3.00
Effect of Exchange Rate Changes	25	-48	29	-6.00	-28	34	-20	-3.00	12	44	-38
Other Net Changes in Cash	11	-	-	-	-	-	-	-	-	-	-
Cash Interest Paid	12	18	13	23	13	26	13	19	11	9.00	27
Cash Income Taxes Paid	37	59	50	71	39	52	24	86	49	34	15

This table presents Xylem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	16,493	16,112	7,952	8,276	8,750	7,710	7,222	6,860	6,474	4,657
Total Current Assets	4,098	3,884	3,012	3,160	3,523	2,450	2,094	2,071	1,839	2,005
Cash & Equivalents	1,121	1,019	944	1,349	1,875	724	296	414	308	680
Accounts Receivable	1,668	1,617	1,096	953	923	1,036	1,031	956	843	749
Inventories, net	996	1,018	799	700	558	539	595	524	522	433
Prepaid Expenses	236	230	173	158	167	151	172	177	166	143
Other Current Nonoperating Assets	77	0.00	-	-	-	-	-	-	-	-
Plant, Property, & Equipment, net	1,152	1,169	630	644	657	658	656	643	616	439
Total Noncurrent Assets	11,243	11,059	4,310	4,472	4,570	4,602	4,472	4,146	4,019	2,213
Goodwill	7,980	7,587	2,719	2,792	2,854	2,839	2,976	2,768	2,632	1,584
Intangible Assets	2,379	2,529	930	1,016	1,093	1,174	1,232	1,168	1,201	435
Other Noncurrent Operating Assets	884	943	661	664	623	589	264	210	186	194
Total Liabilities & Shareholders' Equity	16,493	16,112	7,952	8,276	8,750	7,710	7,222	6,860	6,474	4,657
Total Liabilities	5,611	5,936	4,449	5,050	5,774	4,743	4,440	4,341	4,267	2,573
Total Current Liabilities	2,336	2,205	1,590	1,391	1,956	1,501	1,389	1,100	1,238	823
Short-Term Debt	38	16	0.00	-	600	276	257	0.00	260	78
Accounts Payable	1,006	968	723	639	569	597	586	549	457	338
Accrued Expenses	1,271	1,221	867	752	787	628	546	551	521	407
Other Current Nonoperating Liabilities	21	0.00	-	-	-	-	-	-	-	-
Total Noncurrent Liabilities	3,275	3,731	2,859	3,659	3,818	3,242	3,051	3,241	3,029	1,750
Long-Term Debt	1,978	2,268	1,880	2,440	2,484	2,040	2,051	2,200	2,108	1,196
Noncurrent Deferred & Payable Income Tax Liabilities	497	557	222	287	242	310	303	252	352	118
Noncurrent Employee Benefit Liabilities	304	344	286	438	519	445	400	442	408	335
Other Noncurrent Operating Liabilities	496	562	471	494	573	447	297	347	161	101
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	235	0.00	-	-	-	-	-	-	-	-
Total Equity & Noncontrolling Interests	10,647	10,176	3,503	3,226	2,976	2,967	2,782	2,519	2,207	2,084
Total Preferred & Common Equity	10,642	10,166	3,494	3,218	2,968	2,957	2,768	2,503	2,190	2,084
Total Common Equity	10,642	10,166	3,494	3,218	2,968	2,957	2,768	2,503	2,190	2,084
Common Stock	8,690	8,567	2,136	2,091	2,039	1,993	1,952	1,914	1,878	1,836
Retained Earnings	3,140	2,601	2,292	2,154	1,930	1,866	1,639	1,227	1,033	885
Treasury Stock	-753	-733	-708	-656	-588	-527	-487	-428	-403	-399
Accumulated Other Comprehensive Income / (Loss)	-435	-269	-226	-371	-413	-375	-336	-210	-318	-238
Noncontrolling Interest	5.00	10	9.00	8.00	8.00	10	14	16	17	0.00

This table presents Xylem's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	16,559	16,493	16,046	15,765	15,924	16,112	15,905	16,097	7,940	7,952	8,106
Total Current Assets	4,084	4,098	4,013	3,781	3,893	3,884	3,651	3,735	3,010	3,012	3,191
Cash & Equivalents	1,059	1,121	989	815	947	1,019	705	708	837	944	1,186
Accounts Receivable	1,743	1,668	1,707	1,675	1,641	1,617	1,653	1,659	1,123	1,096	1,018
Inventories, net	1,022	996	1,091	1,057	1,039	1,018	1,080	1,143	857	799	837
Prepaid Expenses	260	236	226	234	266	230	213	225	193	173	150
Other Current Nonoperating Assets	0.00	77	-	-	-	0.00	-	-	-	-	-
Plant, Property, & Equipment, net	1,157	1,152	1,158	1,144	1,141	1,169	1,132	1,144	631	630	585
Total Noncurrent Assets	11,318	11,243	10,875	10,840	10,890	11,059	11,122	11,218	4,299	4,310	4,330
Goodwill	8,061	7,980	7,593	7,509	7,509	7,587	7,149	7,108	2,738	2,719	2,637
Intangible Assets	2,332	2,379	2,326	2,374	2,454	2,529	3,039	3,188	915	930	933
Other Noncurrent Operating Assets	925	884	956	957	927	943	934	922	646	661	760
Total Liabilities & Shareholders' Equity	16,559	16,493	16,046	15,765	15,924	16,112	15,905	16,097	7,940	7,952	8,106
Total Liabilities	5,505	5,611	5,446	5,417	5,721	5,936	5,964	6,187	4,351	4,449	4,884
Total Current Liabilities	2,166	2,336	2,052	2,042	2,331	2,205	2,120	2,282	1,494	1,590	1,929
Short-Term Debt	41	38	17	17	285	16	17	240	0.00	0.00	483
Accounts Payable	958	1,006	930	940	948	968	943	968	710	723	618
Accrued Expenses	1,167	1,271	1,105	1,085	1,098	1,221	1,160	1,074	784	867	828
Other Current Nonoperating Liabilities	0.00	21	-	-	-	0.00	-	-	-	-	-
Total Noncurrent Liabilities	3,339	3,275	3,394	3,375	3,390	3,731	3,844	3,905	2,857	2,859	2,955
Long-Term Debt	1,974	1,978	1,977	1,981	1,985	2,268	2,253	2,267	1,881	1,880	1,880
Noncurrent Deferred & Payable Income Tax Liabilities	486	497	535	552	558	557	724	738	215	222	260
Noncurrent Employee Benefit Liabilities	317	304	332	325	323	344	281	293	285	286	361
Other Noncurrent Operating Liabilities	562	496	550	517	524	562	586	607	476	471	454
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	232	235	-	-	-	0.00	-	-	-	-	-
Total Equity & Noncontrolling Interests	10,822	10,647	10,600	10,348	10,203	10,176	9,941	9,910	3,589	3,503	3,222
Total Preferred & Common Equity	10,816	10,642	10,593	10,341	10,195	10,166	9,930	9,899	3,578	3,494	3,215
Total Common Equity	10,816	10,642	10,593	10,341	10,195	10,166	9,930	9,899	3,578	3,494	3,215
Common Stock	8,708	8,690	8,676	8,663	8,621	8,567	8,532	8,498	2,154	2,136	2,125
Retained Earnings	3,211	3,140	2,902	2,774	2,667	2,601	2,416	2,344	2,331	2,292	2,197
Treasury Stock	-766	-753	-753	-751	-748	-733	-718	-717	-716	-708	-708
Accumulated Other Comprehensive Income / (Loss)	-337	-435	-232	-345	-345	-269	-300	-226	-191	-226	-399
Noncontrolling Interest	6.00	5.00	7.00	7.00	8.00	10	11	11	11	9.00	7.00

This table displays calculated financial ratios and metrics derived from Xylem's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	16.27%	33.36%	6.29%	6.54%	-7.11%	0.81%	10.62%	24.82%	3.23%	-6.72%
EBITDA Growth	37.59%	54.27%	-12.74%	35.73%	-17.16%	-20.26%	18.67%	39.39%	-5.08%	-4.21%
EBIT Growth	43.13%	39.59%	-16.52%	62.15%	-25.05%	-27.59%	21.72%	33.66%	-10.48%	-3.58%
NOPAT Growth	32.12%	24.60%	2.66%	49.45%	-30.18%	-23.67%	57.01%	25.29%	-17.64%	2.21%
Net Income Growth	46.14%	71.55%	-16.86%	68.11%	-36.66%	-26.96%	66.36%	26.92%	-23.53%	0.89%
EPS Growth	30.82%	42.35%	-16.60%	67.86%	-36.65%	-27.06%	65.57%	26.21%	-22.46%	2.19%
Operating Cash Flow Growth	50.90%	40.44%	10.78%	-34.71%	-1.79%	43.17%	-14.58%	38.03%	7.11%	11.54%
Free Cash Flow Firm Growth	108.56%	-1,778.78%	6.45%	-49.10%	-0.34%	463.89%	-64.65%	127.64%	-384.53%	-21.48%
Invested Capital Growth	2.45%	157.74%	2.83%	3.15%	-8.20%	-4.90%	11.36%	0.89%	59.34%	-2.55%
Revenue Q/Q Growth	1.64%	9.06%	3.43%	-0.95%	0.04%	-0.29%	2.14%	4.02%	2.75%	-1.30%
EBITDA Q/Q Growth	0.85%	9.70%	9.67%	-4.91%	-2.70%	-0.80%	4.50%	8.31%	-1.58%	-0.51%
EBIT Q/Q Growth	0.82%	3.32%	14.75%	-6.38%	-3.72%	-1.02%	5.37%	10.93%	-7.24%	0.22%
NOPAT Q/Q Growth	-3.70%	22.31%	4.97%	-7.93%	16.28%	-20.71%	34.50%	6.90%	-17.08%	5.83%
Net Income Q/Q Growth	7.23%	23.78%	11.29%	-7.58%	13.39%	-21.06%	39.34%	6.45%	-19.75%	5.59%
EPS Q/Q Growth	4.58%	14.34%	11.36%	-7.84%	13.82%	-21.07%	38.99%	6.40%	-19.44%	6.86%
Operating Cash Flow Q/Q Growth	10.50%	12.50%	31.28%	-21.80%	-2.14%	29.28%	-15.68%	13.95%	3.97%	9.69%
Free Cash Flow Firm Q/Q Growth	-28.04%	3.32%	-0.32%	-40.02%	1.12%	23.24%	-31.20%	126.35%	-518.30%	-19.13%
Invested Capital Q/Q Growth	1.00%	-0.56%	0.91%	0.35%	-4.15%	-4.58%	0.76%	-3.97%	53.60%	-1.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.51%	36.90%	37.74%	38.02%	37.53%	38.98%	38.91%	39.24%	38.77%	38.43%
EBITDA Margin	18.00%	15.21%	13.15%	16.02%	12.57%	14.10%	17.82%	16.61%	14.88%	16.18%
Operating Margin	11.78%	8.85%	11.26%	11.26%	7.53%	9.26%	12.56%	11.73%	10.82%	12.29%
EBIT Margin	11.43%	9.29%	8.87%	11.30%	7.42%	9.20%	12.81%	11.64%	10.87%	12.54%
Profit (Net Income) Margin	10.39%	8.27%	6.43%	8.22%	5.21%	7.64%	10.54%	7.01%	6.89%	9.31%
Tax Burden Percent	81.88%	95.91%	80.68%	83.56%	89.12%	96.39%	93.85%	70.82%	76.47%	84.37%
Interest Burden Percent	111.03%	92.84%	89.80%	87.05%	78.73%	86.13%	87.71%	85.04%	82.93%	87.99%
Effective Tax Rate	18.12%	4.09%	19.32%	16.44%	10.88%	3.61%	6.15%	29.18%	23.53%	15.63%
Return on Invested Capital (ROIC)	7.13%	7.88%	11.46%	11.50%	7.48%	10.02%	13.49%	9.12%	8.98%	13.96%
ROIC Less NNEP Spread (ROIC-NNEP)	13.20%	6.39%	-3.03%	6.12%	2.26%	6.27%	10.08%	5.95%	5.07%	7.57%
Return on Net Nonoperating Assets (RNNOA)	1.32%	1.03%	-0.91%	2.27%	1.07%	3.93%	7.22%	4.84%	3.13%	2.19%
Return on Equity (ROE)	8.45%	8.90%	10.55%	13.77%	8.55%	13.95%	20.71%	13.97%	12.12%	16.15%
Cash Return on Invested Capital (CROIC)	4.72%	-80.31%	8.68%	8.39%	16.04%	15.04%	2.74%	8.23%	-36.77%	16.54%
Operating Return on Assets (OROA)	6.01%	5.68%	6.04%	6.90%	4.40%	6.47%	9.47%	8.22%	7.37%	9.65%
Return on Assets (ROA)	5.46%	5.06%	4.38%	5.02%	3.09%	5.37%	7.80%	4.95%	4.67%	7.17%
Return on Common Equity (ROCE)	8.35%	8.89%	10.52%	13.73%	8.52%	13.89%	20.60%	13.87%	12.07%	16.15%
Return on Equity Simple (ROE_SIMPLE)	8.36%	5.99%	10.16%	13.27%	8.56%	13.56%	19.83%	13.18%	11.87%	16.31%
Net Operating Profit after Tax (NOPAT)	826	625	502	489	327	468	614	391	312	379
NOPAT Margin	9.65%	8.49%	9.09%	9.41%	6.71%	8.93%	11.79%	8.30%	8.27%	10.37%
Net Nonoperating Expense Percent (NNEP)	-6.07%	1.48%	14.49%	5.38%	5.22%	3.74%	3.41%	3.17%	3.92%	6.39%
Return On Investment Capital (ROIC_SIMPLE)	6.52%	5.02%	9.32%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	62.49%	63.10%	62.26%	61.98%	62.47%	61.02%	61.09%	60.76%	61.23%	61.57%
SG&A Expenses to Revenue	22.32%	23.86%	22.22%	22.69%	23.44%	22.06%	22.30%	23.14%	24.24%	23.38%
R&D to Revenue	2.69%	3.15%	3.73%	3.93%	3.84%	3.64%	3.63%	3.85%	2.92%	2.60%
Operating Expenses to Revenue	25.73%	28.04%	26.48%	26.76%	30.00%	29.72%	26.35%	27.51%	27.95%	26.14%
Earnings before Interest and Taxes (EBIT)	979	684	490	587	362	483	667	548	410	458
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,541	1,120	726	832	613	740	928	782	561	591
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.64	2.67	5.55	6.51	5.93	4.55	4.05	4.52	3.70	2.83
Price to Tangible Book Value (P/TBV)	99.29	543.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	90.65
Price to Revenue (P/Rev)	3.28	3.69	3.51	4.03	3.61	2.56	2.15	2.41	2.15	1.61
Price to Earnings (P/E)	31.57	44.64	54.64	49.08	69.34	33.52	20.43	34.21	31.19	17.33
Dividend Yield	1.25%	1.17%	1.12%	0.96%	1.06%	1.29%	1.35%	1.14%	1.37%	1.71%
Earnings Yield	3.17%	2.24%	1.83%	2.04%	1.44%	2.98%	4.89%	2.92%	3.21%	5.77%
Enterprise Value to Invested Capital (EV/IC)	2.49	2.49	4.58	5.11	4.50	3.30	2.76	3.05	2.39	2.42
Enterprise Value to Revenue (EV/Rev)	3.41	3.86	3.68	4.25	3.86	2.87	2.54	2.79	2.70	1.78
Enterprise Value to EBITDA (EV/EBITDA)	18.97	25.41	28.02	26.51	30.71	20.33	14.27	16.79	18.16	10.98
Enterprise Value to EBIT (EV/EBIT)	29.86	41.61	41.51	37.57	52.01	31.15	19.86	23.95	24.84	14.16
Enterprise Value to NOPAT (EV/NOPAT)	35.39	45.51	40.53	45.12	57.56	32.11	21.58	33.58	32.65	17.12
Enterprise Value to Operating Cash Flow (EV/OCF)	23.15	34.00	34.13	41.00	22.85	17.93	22.60	19.14	20.49	13.98
Enterprise Value to Free Cash Flow (EV/FCFF)	53.53	0.00	53.55	61.81	26.86	21.39	106.16	37.20	0.00	14.45
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.19	0.22	0.54	0.76	1.04	0.78	0.83	0.87	1.07	0.61
Long-Term Debt to Equity	0.18	0.22	0.54	0.76	0.83	0.69	0.74	0.87	0.96	0.57
Financial Leverage	0.10	0.16	0.30	0.37	0.47	0.63	0.72	0.81	0.62	0.29
Leverage Ratio	1.55	1.76	2.41	2.75	2.77	2.60	2.66	2.82	2.59	2.25
Compound Leverage Factor	1.72	1.63	2.17	2.39	2.18	2.24	2.33	2.40	2.15	1.98
Debt to Total Capital	15.63%	18.33%	34.92%	43.06%	50.89%	43.84%	45.34%	46.62%	51.76%	37.94%
Short-Term Debt to Total Capital	0.29%	0.13%	0.00%	0.00%	9.90%	5.22%	5.05%	0.00%	5.68%	2.32%
Long-Term Debt to Total Capital	15.34%	18.20%	34.92%	43.06%	40.99%	38.61%	40.29%	46.62%	46.08%	35.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.86%	0.08%	0.17%	0.14%	0.13%	0.19%	0.28%	0.34%	0.37%	0.00%
Common Equity to Total Capital	82.51%	81.59%	64.91%	56.79%	48.98%	55.97%	54.38%	53.04%	47.87%	62.06%
Debt to EBITDA	1.31	2.04	2.59	2.93	5.03	3.13	2.49	2.81	4.22	2.16
Net Debt to EBITDA	0.58	1.13	1.29	1.31	1.97	2.15	2.17	2.28	3.67	1.01
Long-Term Debt to EBITDA	1.28	2.03	2.59	2.93	4.05	2.76	2.21	2.81	3.76	2.02
Debt to NOPAT	2.44	3.65	3.75	4.99	9.43	4.94	3.76	5.63	7.59	3.36
Net Debt to NOPAT	1.08	2.02	1.87	2.23	3.70	3.40	3.28	4.57	6.60	1.57
Long-Term Debt to NOPAT	2.39	3.63	3.75	4.99	7.59	4.35	3.34	5.63	6.76	3.16
Altman Z-Score	4.11	3.70	4.13	3.97	3.05	3.07	2.98	2.94	2.27	3.05
Noncontrolling Interest Sharing Ratio	1.19%	0.14%	0.25%	0.26%	0.30%	0.42%	0.57%	0.70%	0.40%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.75	1.76	1.89	2.27	1.80	1.63	1.51	1.88	1.49	2.44
Quick Ratio	1.19	1.20	1.28	1.65	1.43	1.17	0.96	1.25	0.93	1.74
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	546	-6,377	380	357	701	703	125	353	-1,277	449
Operating Cash Flow to CapEx	398.42%	310.00%	292.16%	262.44%	450.27%	371.24%	247.26%	405.92%	404.07%	396.58%
Free Cash Flow to Firm to Interest Expense	12.41	-130.14	7.60	4.70	9.10	10.50	1.52	4.30	-18.24	8.16
Operating Cash Flow to Interest Expense	28.70	17.08	11.92	7.08	10.70	12.52	7.15	8.37	7.10	8.44
Operating Cash Flow Less CapEx to Interest Expense	21.50	11.57	7.84	4.38	8.32	9.15	4.26	6.30	5.34	6.31
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.61	0.68	0.61	0.59	0.70	0.74	0.71	0.68	0.77
Accounts Receivable Turnover	5.21	5.43	5.39	5.54	4.98	5.08	5.24	5.23	4.74	4.81
Inventory Turnover	5.31	5.12	4.59	5.12	5.55	5.65	5.69	5.47	4.84	4.89
Fixed Asset Turnover	7.38	8.19	8.67	7.99	7.42	7.99	8.02	7.48	7.15	8.12
Accounts Payable Turnover	5.42	5.50	5.05	5.33	5.22	5.42	5.61	5.69	5.81	6.65
Days Sales Outstanding (DSO)	70.02	67.24	67.72	65.90	73.32	71.87	69.64	69.75	77.05	75.94
Days Inventory Outstanding (DIO)	68.70	71.36	79.57	71.30	65.73	64.61	64.20	66.75	75.48	74.57
Days Payable Outstanding (DPO)	67.34	66.41	72.30	68.47	69.86	67.40	65.12	64.19	62.84	54.86
Cash Conversion Cycle (CCC)	71.38	72.18	74.99	68.74	69.19	69.07	68.72	72.30	89.69	95.66
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	11,721	11,441	4,439	4,317	4,185	4,559	4,794	4,305	4,267	2,678
Invested Capital Turnover	0.74	0.93	1.26	1.22	1.12	1.12	1.14	1.10	1.09	1.35
Increase / (Decrease) in Invested Capital	280	7,002	122	132	-374	-235	489	38	1,589	-70
Enterprise Value (EV)	29,234	28,459	20,341	22,056	18,828	15,044	13,244	13,127	10,186	6,486
Market Capitalization	28,099	27,184	19,396	20,957	17,611	13,442	11,218	11,325	8,109	5,892
Book Value per Share	$43.80	$42.17	$19.39	$17.85	$16.47	$16.42	$15.40	$13.94	$12.21	$11.62
Tangible Book Value per Share	$1.16	$0.21	($0.86)	($3.27)	($5.43)	($5.86)	($8.01)	($7.98)	($9.16)	$0.36
Total Capital	12,898	12,460	5,383	5,666	6,060	5,283	5,090	4,719	4,575	3,358
Total Debt	2,016	2,284	1,880	2,440	3,084	2,316	2,308	2,200	2,368	1,274
Total Long-Term Debt	1,978	2,268	1,880	2,440	2,484	2,040	2,051	2,200	2,108	1,196
Net Debt	895	1,265	936	1,091	1,209	1,592	2,012	1,786	2,060	594
Capital Expenditures (CapEx)	317	270	204	205	183	226	237	169	123	117
Debt-free, Cash-free Net Working Capital (DFCFNWC)	679	676	478	420	292	501	666	557	553	580
Debt-free Net Working Capital (DFNWC)	1,800	1,695	1,422	1,769	2,167	1,225	962	971	861	1,260
Net Working Capital (NWC)	1,762	1,679	1,422	1,769	1,567	949	705	971	601	1,182
Net Nonoperating Expense (NNE)	-64	16	147	62	73	67	65	61	52	39
Net Nonoperating Obligations (NNO)	839	1,265	936	1,091	1,209	1,592	2,012	1,786	2,060	594
Total Depreciation and Amortization (D&A)	562	436	236	245	251	257	261	234	151	133
Debt-free, Cash-free Net Working Capital to Revenue	7.93%	9.18%	8.66%	8.08%	5.99%	9.54%	12.79%	11.83%	14.66%	15.88%
Debt-free Net Working Capital to Revenue	21.02%	23.02%	25.75%	34.05%	44.44%	23.34%	18.48%	20.63%	22.83%	34.49%
Net Working Capital to Revenue	20.58%	22.80%	25.75%	34.05%	32.14%	18.08%	13.54%	20.63%	15.94%	32.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.67	$2.81	$1.97	$2.37	$1.41	$2.23	$3.05	$1.84	$1.45	$1.88
Adjusted Weighted Average Basic Shares Outstanding	242.58M	217.01M	180.22M	180.25M	180.12M	180M	179.78M	179.63M	179.11M	180.89M
Adjusted Diluted Earnings per Share	$3.65	$2.79	$1.96	$2.35	$1.40	$2.21	$3.03	$1.83	$1.45	$1.87
Adjusted Weighted Average Diluted Shares Outstanding	243.52M	218.18M	180.98M	181.53M	181.10M	181.20M	181.13M	180.86M	180.04M	181.74M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	243.05M	241.77M	180.28M	179.90M	180.36M	180.22M	179.55M	179.89M	179.47M	178.49M
Normalized Net Operating Profit after Tax (NOPAT)	877	698	525	495	446	672	634	409	335	384
Normalized NOPAT Margin	10.24%	9.48%	9.51%	9.52%	9.14%	12.80%	12.18%	8.68%	8.88%	10.51%
Pre Tax Income Margin	12.70%	8.62%	7.97%	9.84%	5.85%	7.93%	11.23%	9.90%	9.02%	11.03%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	22.25	13.96	9.80	7.72	4.70	7.21	8.13	6.68	5.86	8.33
NOPAT to Interest Expense	18.78	12.76	10.04	6.43	4.25	6.99	7.48	4.77	4.46	6.89
EBIT Less CapEx to Interest Expense	15.05	8.45	5.72	5.03	2.32	3.84	5.24	4.62	4.10	6.20
NOPAT Less CapEx to Interest Expense	11.57	7.25	5.96	3.73	1.87	3.62	4.59	2.71	2.70	4.76
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	39.33%	49.10%	61.13%	47.54%	74.02%	43.39%	27.69%	39.39%	43.08%	30.00%
Augmented Payout Ratio	41.57%	53.20%	75.77%	63.47%	98.03%	53.37%	38.43%	46.97%	44.62%	82.65%

This table displays calculated financial ratios and metrics derived from Xylem's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.77%	6.52%	1.35%	25.96%	40.40%	40.64%	50.43%	26.25%	13.84%	13.83%	9.09%
EBITDA Growth	7.56%	3.60%	21.39%	84.86%	76.41%	37.79%	297.70%	4.81%	15.38%	32.32%	-59.72%
EBIT Growth	7.14%	3.57%	40.20%	104.76%	55.56%	10.89%	586.21%	-14.86%	21.62%	45.32%	-81.17%
NOPAT Growth	8.97%	-13.15%	43.93%	106.92%	58.51%	72.09%	32.33%	-20.13%	10.82%	23.70%	-8.98%
Net Income Growth	9.15%	22.56%	42.76%	110.87%	54.55%	78.52%	1,166.67%	-17.86%	20.73%	31.86%	-89.47%
EPS Growth	9.52%	13.68%	41.27%	77.78%	16.67%	42.68%	800.00%	-27.42%	20.00%	32.26%	-88.89%
Operating Cash Flow Growth	-62.92%	26.37%	-16.62%	928.57%	568.42%	25.69%	84.65%	-75.22%	76.54%	64.55%	80.36%
Free Cash Flow Firm Growth	95.45%	99.29%	101.83%	105.29%	-83,278.70%	-20,320.25%	-32,293.79%	-7,416.47%	92.74%	616.83%	-88.89%
Invested Capital Growth	4.20%	2.45%	0.86%	-1.52%	148.78%	157.74%	161.56%	160.78%	2.45%	2.83%	2.25%
Revenue Q/Q Growth	-8.29%	7.22%	-3.00%	6.69%	-4.01%	2.02%	20.56%	18.92%	-3.85%	9.13%	1.17%
EBITDA Q/Q Growth	-1.07%	-10.95%	4.22%	17.15%	-4.71%	4.34%	58.72%	11.79%	-25.57%	201.15%	-58.17%
EBIT Q/Q Growth	-3.02%	-16.85%	8.14%	22.86%	-6.25%	12.56%	57.94%	-6.67%	-33.17%	596.55%	-80.41%
NOPAT Q/Q Growth	-23.41%	2.76%	13.67%	21.80%	-38.96%	70.31%	63.41%	-6.70%	-33.73%	30.96%	-1.37%
Net Income Q/Q Growth	-48.77%	50.23%	11.86%	26.80%	-42.48%	75.00%	65.22%	-7.07%	-33.56%	1,141.67%	-89.29%
EPS Q/Q Growth	-48.12%	49.44%	11.25%	26.98%	-46.15%	85.71%	40.00%	-16.67%	-34.15%	1,071.43%	-88.71%
Operating Cash Flow Q/Q Growth	-94.26%	84.89%	7.99%	223.60%	-80.44%	21.98%	1,232.14%	247.37%	-105.25%	79.21%	78.76%
Free Cash Flow Firm Q/Q Growth	-539.46%	-137.74%	-66.32%	105.60%	0.07%	3.10%	2.43%	-88,149.12%	-124.23%	54.28%	122.78%
Invested Capital Q/Q Growth	2.47%	1.00%	0.64%	0.04%	0.74%	-0.56%	-1.73%	152.73%	4.37%	0.91%	-2.03%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.12%	37.99%	37.26%	37.76%	36.99%	35.69%	36.80%	37.80%	37.71%	38.05%	37.97%
EBITDA Margin	17.88%	16.58%	19.96%	18.58%	16.92%	17.04%	16.67%	12.66%	13.47%	17.40%	6.30%
Operating Margin	11.16%	11.84%	13.31%	11.66%	10.28%	9.96%	9.20%	6.91%	9.05%	13.08%	12.17%
EBIT Margin	10.87%	10.28%	13.26%	11.89%	10.33%	10.58%	9.59%	7.32%	9.32%	13.41%	2.10%
Profit (Net Income) Margin	8.07%	14.45%	10.31%	8.94%	7.53%	12.56%	7.32%	5.34%	6.84%	9.89%	0.87%
Tax Burden Percent	76.96%	86.93%	80.67%	78.54%	78.06%	126.67%	82.16%	80.70%	78.57%	78.84%	70.59%
Interest Burden Percent	96.44%	161.64%	96.42%	95.74%	93.33%	93.75%	92.96%	90.48%	93.33%	93.56%	58.62%
Effective Tax Rate	23.04%	13.07%	19.33%	21.46%	21.94%	-26.67%	17.84%	19.30%	21.43%	21.16%	29.41%
Return on Invested Capital (ROIC)	6.28%	7.61%	7.83%	6.62%	7.90%	11.70%	6.42%	4.17%	8.85%	13.01%	10.55%
ROIC Less NNEP Spread (ROIC-NNEP)	5.33%	16.53%	7.14%	6.30%	7.04%	11.59%	6.06%	3.91%	8.52%	12.39%	1.58%
Return on Net Nonoperating Assets (RNNOA)	0.57%	1.65%	0.89%	0.93%	1.21%	1.86%	1.26%	0.92%	2.96%	3.73%	0.59%
Return on Equity (ROE)	6.85%	9.26%	8.72%	7.55%	9.10%	13.57%	7.68%	5.09%	11.81%	16.74%	11.14%
Cash Return on Invested Capital (CROIC)	3.04%	4.72%	6.57%	8.32%	-76.82%	-80.31%	-82.94%	-83.14%	8.72%	8.68%	8.76%
Operating Return on Assets (OROA)	5.76%	5.40%	6.99%	6.27%	6.88%	6.47%	5.39%	3.65%	6.58%	9.13%	1.38%
Return on Assets (ROA)	4.27%	7.59%	5.44%	4.71%	5.01%	7.69%	4.12%	2.66%	4.82%	6.73%	0.57%
Return on Common Equity (ROCE)	6.77%	9.15%	8.71%	7.54%	9.09%	13.55%	7.67%	5.08%	11.77%	16.70%	11.11%
Return on Equity Simple (ROE_SIMPLE)	8.36%	0.00%	7.84%	7.40%	6.50%	0.00%	4.95%	3.56%	10.40%	0.00%	9.92%
Net Operating Profit after Tax (NOPAT)	178	232	226	199	163	267	157	96	103	155	119
NOPAT Margin	8.59%	10.29%	10.74%	9.16%	8.03%	12.62%	7.56%	5.58%	7.11%	10.31%	8.59%
Net Nonoperating Expense Percent (NNEP)	0.95%	-8.92%	0.69%	0.32%	0.86%	0.12%	0.36%	0.26%	0.33%	0.62%	8.97%
Return On Investment Capital (ROIC_SIMPLE)	1.38%	1.83%	-	-	-	2.15%	-	-	-	2.89%	-
Cost of Revenue to Revenue	62.88%	62.01%	62.74%	62.24%	63.01%	64.31%	63.20%	62.20%	62.29%	61.95%	62.03%
SG&A Expenses to Revenue	22.23%	22.47%	21.15%	22.36%	23.32%	22.00%	23.65%	25.90%	24.45%	20.92%	21.30%
R&D to Revenue	2.71%	2.57%	2.61%	2.67%	2.90%	2.83%	2.94%	3.37%	3.66%	3.59%	3.41%
Operating Expenses to Revenue	25.95%	26.15%	23.95%	26.10%	26.71%	25.73%	27.60%	30.89%	28.66%	24.97%	25.80%
Earnings before Interest and Taxes (EBIT)	225	232	279	258	210	224	199	126	135	202	29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	370	374	420	403	344	361	346	218	195	262	87
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.68	2.64	3.10	3.18	3.05	2.67	2.18	2.03	5.19	5.55	4.79
Price to Tangible Book Value (P/TBV)	68.64	99.29	48.66	71.80	133.95	543.69	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	3.38	3.28	3.89	3.92	3.91	3.69	3.21	3.32	3.26	3.51	2.89
Price to Earnings (P/E)	32.05	31.57	39.52	42.98	46.87	44.64	44.05	57.10	49.97	54.64	48.31
Dividend Yield	1.24%	1.25%	1.04%	1.02%	1.05%	1.17%	1.43%	1.13%	1.19%	1.12%	1.38%
Earnings Yield	3.12%	3.17%	2.53%	2.33%	2.13%	2.24%	2.27%	1.75%	2.00%	1.83%	2.07%
Enterprise Value to Invested Capital (EV/IC)	2.52	2.49	2.91	2.95	2.81	2.49	2.02	1.87	4.24	4.58	3.77
Enterprise Value to Revenue (EV/Rev)	3.52	3.41	4.01	4.06	4.08	3.86	3.44	3.62	3.45	3.68	3.11
Enterprise Value to EBITDA (EV/EBITDA)	19.29	18.97	22.13	23.43	25.54	25.41	22.77	28.75	26.12	28.02	25.07
Enterprise Value to EBIT (EV/EBIT)	30.41	29.86	34.82	38.24	42.70	41.61	35.12	44.53	38.21	41.51	38.87
Enterprise Value to NOPAT (EV/NOPAT)	35.94	35.39	39.41	43.20	47.20	45.51	45.48	45.14	38.49	40.53	34.71
Enterprise Value to Operating Cash Flow (EV/OCF)	25.04	23.15	29.58	28.28	34.29	34.00	31.25	38.23	29.85	34.13	36.55
Enterprise Value to Free Cash Flow (EV/FCFF)	84.63	53.53	44.55	35.25	0.00	0.00	0.00	0.00	49.19	53.55	43.55
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.18	0.19	0.19	0.19	0.22	0.22	0.23	0.25	0.52	0.54	0.73
Long-Term Debt to Equity	0.18	0.18	0.19	0.19	0.19	0.22	0.23	0.23	0.52	0.54	0.58
Financial Leverage	0.11	0.10	0.13	0.15	0.17	0.16	0.21	0.24	0.35	0.30	0.38
Leverage Ratio	1.53	1.55	1.56	1.57	1.73	1.76	1.82	1.85	2.38	2.41	2.57
Compound Leverage Factor	1.47	2.50	1.50	1.51	1.61	1.65	1.70	1.68	2.22	2.26	1.51
Debt to Total Capital	15.42%	15.63%	15.83%	16.18%	18.20%	18.33%	18.59%	20.19%	34.39%	34.92%	42.31%
Short-Term Debt to Total Capital	0.31%	0.29%	0.14%	0.14%	2.28%	0.13%	0.14%	1.93%	0.00%	0.00%	8.65%
Long-Term Debt to Total Capital	15.10%	15.34%	15.70%	16.05%	15.91%	18.20%	18.45%	18.26%	34.39%	34.92%	33.66%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.82%	1.86%	0.06%	0.06%	0.06%	0.08%	0.09%	0.09%	0.20%	0.17%	0.13%
Common Equity to Total Capital	82.76%	82.51%	84.11%	83.76%	81.74%	81.59%	81.32%	79.72%	65.41%	64.91%	57.56%
Debt to EBITDA	1.29	1.31	1.31	1.37	1.79	2.04	2.22	3.29	2.50	2.59	3.57
Net Debt to EBITDA	0.61	0.58	0.66	0.81	1.04	1.13	1.53	2.36	1.39	1.29	1.78
Long-Term Debt to EBITDA	1.26	1.28	1.29	1.36	1.56	2.03	2.21	2.98	2.50	2.59	2.84
Debt to NOPAT	2.40	2.44	2.32	2.53	3.31	3.65	4.44	5.17	3.69	3.75	4.94
Net Debt to NOPAT	1.14	1.08	1.17	1.50	1.93	2.02	3.06	3.71	2.05	1.87	2.46
Long-Term Debt to NOPAT	2.35	2.39	2.30	2.51	2.89	3.63	4.41	4.67	3.69	3.75	3.93
Altman Z-Score	4.14	3.97	4.60	4.61	4.15	3.60	2.97	2.66	3.98	4.01	3.13
Noncontrolling Interest Sharing Ratio	1.16%	1.19%	0.09%	0.09%	0.14%	0.14%	0.14%	0.14%	0.28%	0.25%	0.25%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.89	1.75	1.96	1.85	1.67	1.76	1.72	1.64	2.01	1.89	1.65
Quick Ratio	1.29	1.19	1.31	1.22	1.11	1.20	1.11	1.04	1.31	1.28	1.14
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-306	-48	127	377	-6,730	-6,735	-6,950	-7,123	-8.07	33	22
Operating Cash Flow to CapEx	50.00%	580.81%	420.27%	405.63%	121.92%	478.95%	518.06%	51.85%	-38.78%	613.56%	381.13%
Free Cash Flow to Firm to Interest Expense	-38.28	-5.32	12.69	34.25	-480.70	-481.05	-496.43	-593.58	-0.90	2.56	1.80
Operating Cash Flow to Interest Expense	4.13	63.89	31.10	26.18	6.36	32.50	26.64	2.33	-2.11	27.85	16.83
Operating Cash Flow Less CapEx to Interest Expense	-4.13	52.89	23.70	19.73	1.14	25.71	21.50	-2.17	-7.56	23.31	12.42
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.53	0.53	0.53	0.53	0.67	0.61	0.56	0.50	0.71	0.68	0.66
Accounts Receivable Turnover	5.08	5.21	5.01	5.04	5.75	5.43	5.06	4.51	5.34	5.39	5.36
Inventory Turnover	5.21	5.31	4.89	4.82	5.30	5.12	4.40	3.77	4.26	4.59	4.40
Fixed Asset Turnover	7.48	7.38	7.36	7.34	8.97	8.19	7.86	6.91	8.99	8.67	8.88
Accounts Payable Turnover	5.63	5.42	5.67	5.56	6.06	5.50	5.40	4.66	5.19	5.05	5.58
Days Sales Outstanding (DSO)	71.83	70.02	72.79	72.47	63.46	67.24	72.19	80.85	68.35	67.72	68.06
Days Inventory Outstanding (DIO)	70.04	68.70	74.57	75.68	68.85	71.36	82.94	96.78	85.75	79.57	82.96
Days Payable Outstanding (DPO)	64.78	67.34	64.34	65.64	60.20	66.41	67.54	78.39	70.32	72.30	65.39
Cash Conversion Cycle (CCC)	77.10	71.38	83.03	82.51	72.10	72.18	87.60	99.24	83.79	74.99	85.62
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	12,010	11,721	11,605	11,531	11,526	11,441	11,506	11,709	4,633	4,439	4,399
Invested Capital Turnover	0.73	0.74	0.73	0.72	0.98	0.93	0.85	0.75	1.24	1.26	1.23
Increase / (Decrease) in Invested Capital	484	280	99	-178	6,893	7,002	7,107	7,219	111	122	97
Enterprise Value (EV)	30,228	29,234	33,810	34,073	32,407	28,459	23,249	21,908	19,642	20,341	16,596
Market Capitalization	29,034	28,099	32,798	32,883	31,076	27,184	21,673	20,098	18,587	19,396	15,412
Book Value per Share	$44.50	$43.80	$43.61	$42.65	$42.15	$42.17	$41.23	$54.81	$19.85	$19.39	$17.84
Tangible Book Value per Share	$1.74	$1.16	$2.77	$1.89	$0.96	$0.21	($1.07)	($2.20)	($0.42)	($0.86)	($1.97)
Total Capital	13,069	12,898	12,594	12,346	12,473	12,460	12,211	12,417	5,470	5,383	5,585
Total Debt	2,015	2,016	1,994	1,998	2,270	2,284	2,270	2,507	1,881	1,880	2,363
Total Long-Term Debt	1,974	1,978	1,977	1,981	1,985	2,268	2,253	2,267	1,881	1,880	1,880
Net Debt	956	895	1,005	1,183	1,323	1,265	1,565	1,799	1,044	936	1,177
Capital Expenditures (CapEx)	66	99	74	71	73	95	72	54	49	59	53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	900	679	989	941	900	676	843	985	679	478	559
Debt-free Net Working Capital (DFNWC)	1,959	1,800	1,978	1,756	1,847	1,695	1,548	1,693	1,516	1,422	1,745
Net Working Capital (NWC)	1,918	1,762	1,961	1,739	1,562	1,679	1,531	1,453	1,516	1,422	1,262
Net Nonoperating Expense (NNE)	11	-94	8.87	4.71	10	1.27	4.93	4.04	3.93	6.31	107
Net Nonoperating Obligations (NNO)	956	839	1,005	1,183	1,323	1,265	1,565	1,799	1,044	936	1,177
Total Depreciation and Amortization (D&A)	145	142	141	145	134	137	147	92	60	60	58
Debt-free, Cash-free Net Working Capital to Revenue	10.47%	7.93%	11.74%	11.21%	11.32%	9.18%	12.49%	16.26%	11.92%	8.66%	10.47%
Debt-free Net Working Capital to Revenue	22.78%	21.02%	23.48%	20.91%	23.24%	23.02%	22.93%	27.96%	26.61%	25.75%	32.68%
Net Working Capital to Revenue	22.31%	20.58%	23.28%	20.71%	19.65%	22.80%	22.67%	23.99%	26.61%	25.75%	23.64%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.69	$1.35	$0.89	$0.80	$0.63	$1.18	$0.63	$0.45	$0.55	$0.83	$0.07
Adjusted Weighted Average Basic Shares Outstanding	243.11M	242.58M	242.93M	242.57M	241.85M	217.01M	240.87M	205.54M	180.40M	180.22M	180.22M
Adjusted Diluted Earnings per Share	$0.69	$1.33	$0.89	$0.80	$0.63	$1.17	$0.63	$0.45	$0.54	$0.82	$0.07
Adjusted Weighted Average Diluted Shares Outstanding	243.78M	243.52M	243.75M	243.54M	243.02M	218.18M	242.19M	206.74M	181.32M	180.98M	180.94M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	243.35M	243.05M	242.94M	242.89M	242.45M	241.77M	241.08M	240.83M	180.62M	180.28M	180.22M
Normalized Net Operating Profit after Tax (NOPAT)	194	254	229	217	171	161	174	119	109	161	129
Normalized NOPAT Margin	9.37%	11.25%	10.89%	9.99%	8.41%	7.60%	8.39%	6.89%	7.54%	10.68%	9.36%
Pre Tax Income Margin	10.49%	16.62%	12.79%	11.39%	9.64%	9.92%	8.91%	6.62%	8.70%	12.55%	1.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	28.13	25.78	27.90	23.45	15.00	16.00	14.21	10.50	15.00	15.54	2.42
NOPAT to Interest Expense	22.22	25.79	22.59	18.06	11.65	19.09	11.21	8.00	11.44	11.95	9.88
EBIT Less CapEx to Interest Expense	19.88	14.78	20.50	17.00	9.79	9.21	9.07	6.00	9.56	11.00	-2.00
NOPAT Less CapEx to Interest Expense	13.97	14.79	15.19	11.61	6.44	12.30	6.07	3.50	5.99	7.41	5.47
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	39.82%	39.33%	41.33%	43.79%	49.32%	49.10%	55.49%	69.89%	59.68%	61.13%	67.08%
Augmented Payout Ratio	41.81%	41.57%	45.42%	48.24%	54.15%	53.20%	57.52%	72.44%	62.10%	75.77%	83.39%

Frequently Asked Questions About Xylem's Financials

When does Xylem's financial year end?

According to the most recent income statement we have on file, Xylem's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Xylem's net income changed over the last 9 years?

Xylem's net income appears to be on an upward trend, with a most recent value of $890 million in 2024, rising from $340 million in 2015. The previous period was $609 million in 2023. Check out Xylem's forecast to explore projected trends and price targets.

What is Xylem's operating income?

Xylem's total operating income in 2024 was $1.01 billion, based on the following breakdown:

Total Gross Profit: $3.21 billion
Total Operating Expenses: $2.20 billion

How has Xylem revenue changed over the last 9 years?

Over the last 9 years, Xylem's total revenue changed from $3.65 billion in 2015 to $8.56 billion in 2024, a change of 134.4%.

How much debt does Xylem have?

Xylem's total liabilities were at $5.61 billion at the end of 2024, a 5.5% decrease from 2023, and a 118.1% increase since 2015.

How much cash does Xylem have?

In the past 9 years, Xylem's cash and equivalents has ranged from $296 million in 2018 to $1.88 billion in 2020, and is currently $1.12 billion as of their latest financial filing in 2024.

How has Xylem's book value per share changed over the last 9 years?

Over the last 9 years, Xylem's book value per share changed from 11.62 in 2015 to 43.80 in 2024, a change of 277.0%.

Related Companies

This page (NYSE:XYL) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xylem (XYL) Financials

Frequently Asked Questions About Xylem's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Xylem (XYL) Financials

Annual Income Statements for Xylem

Quarterly Income Statements for Xylem

Annual Cash Flow Statements for Xylem

Quarterly Cash Flow Statements for Xylem

Annual Balance Sheets for Xylem

Quarterly Balance Sheets for Xylem

Annual Metrics And Ratios for Xylem

Quarterly Metrics And Ratios for Xylem

Frequently Asked Questions About Xylem's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools